An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)

Shigeru Nakai, Kunitoshi Iseki, Noritomo Itami, Satoshi Ogata, Junichiro James Kazama, Naoki Kimata, Takashi Shigematsu, Toshio Shinoda, Tetsuo Shoji, Kazuyuki Suzuki, Masatomo Taniguchi, Kenji Tsuchida, Hidetomo Nakamoto, Hiroshi Nishi, Seiji Hashimoto, Takeshi Hasegawa, Norio Hanafusa, Takayuki Hamano, Naohiko Fujii, Ikuto MasakaneSeiji Marubayashi, Osamu Morita, Kunihiro Yamagata, Kenji Wakai, Atsushi Wada, Yuzo Watanabe, Yoshiharu Tsubakihara

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

A nationwide statistical survey of 4226 dialysis facilities was conducted at the end of 2010, and 4166 facilities (98.6%) responded. The number of new patients introduced into dialysis was 37512 in 2010. This number has decreased for two consecutive years since it peaked in 2008. The number of patients who died in 2010 was 28882, which has been increasing every year. The number of patients undergoing dialysis at the end of 2010 was 298252, which is an increase of 7591 (2.6%) compared with that at the end of 2009. The number of dialysis patients per million at the end of 2010 was 2329.1. The crude death rate of dialysis patients in 2010 was 9.8%, and has been gradually increasing. The mean age of the new patients introduced into dialysis was 67.8 years and the mean age of the entire dialysis patient population was 66.2 years. Regarding the primary disease of the new patients introduced into dialysis, the percentage of patients with diabetic nephropathy was 43.6%, which is a slight decrease from that in the previous year (44.5%). Patients with diabetic nephropathy as the primary disease accounted for 35.9% of the entire dialysis patient population, which approaches the percentage of patients with chronic glomerulonephritis as the primary disease (36.2%). The percentage of patients who had undergone carpal tunnel release surgery (CTx) was 4.3%, which is a slight decrease from that at the end of 1999 (5.5%). The decrease in the percentage of patients who had undergone CTx was significant among the patients with dialysis durations of 20-24 years (1999, 48.0%; 2010, 23.2%). A total weekly Kt/V attributable to peritoneal dialysis and their residual functional kidney was 1.7 or higher for 59.4% of patients who underwent peritoneal dialysis.

Original languageEnglish (US)
Pages (from-to)483-521
Number of pages39
JournalTherapeutic Apheresis and Dialysis
Volume16
Issue number6
DOIs
StatePublished - Dec 2012

Fingerprint

Dialysis
Japan
Therapeutics
Diabetic Nephropathies
Peritoneal Dialysis
Glomerulonephritis
Wrist
Population

Keywords

  • Combined use of peritoneal dialysis
  • Dementia
  • Dialysis patient population
  • Survey
  • Survival rate

ASJC Scopus subject areas

  • Hematology
  • Nephrology

Cite this

Nakai, S., Iseki, K., Itami, N., Ogata, S., Kazama, J. J., Kimata, N., ... Tsubakihara, Y. (2012). An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010). Therapeutic Apheresis and Dialysis, 16(6), 483-521. https://doi.org/10.1111/j.1744-9987.2012.01143.x

An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010). / Nakai, Shigeru; Iseki, Kunitoshi; Itami, Noritomo; Ogata, Satoshi; Kazama, Junichiro James; Kimata, Naoki; Shigematsu, Takashi; Shinoda, Toshio; Shoji, Tetsuo; Suzuki, Kazuyuki; Taniguchi, Masatomo; Tsuchida, Kenji; Nakamoto, Hidetomo; Nishi, Hiroshi; Hashimoto, Seiji; Hasegawa, Takeshi; Hanafusa, Norio; Hamano, Takayuki; Fujii, Naohiko; Masakane, Ikuto; Marubayashi, Seiji; Morita, Osamu; Yamagata, Kunihiro; Wakai, Kenji; Wada, Atsushi; Watanabe, Yuzo; Tsubakihara, Yoshiharu.

In: Therapeutic Apheresis and Dialysis, Vol. 16, No. 6, 12.2012, p. 483-521.

Research output: Contribution to journalArticle

Nakai, S, Iseki, K, Itami, N, Ogata, S, Kazama, JJ, Kimata, N, Shigematsu, T, Shinoda, T, Shoji, T, Suzuki, K, Taniguchi, M, Tsuchida, K, Nakamoto, H, Nishi, H, Hashimoto, S, Hasegawa, T, Hanafusa, N, Hamano, T, Fujii, N, Masakane, I, Marubayashi, S, Morita, O, Yamagata, K, Wakai, K, Wada, A, Watanabe, Y & Tsubakihara, Y 2012, 'An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)', Therapeutic Apheresis and Dialysis, vol. 16, no. 6, pp. 483-521. https://doi.org/10.1111/j.1744-9987.2012.01143.x
Nakai, Shigeru ; Iseki, Kunitoshi ; Itami, Noritomo ; Ogata, Satoshi ; Kazama, Junichiro James ; Kimata, Naoki ; Shigematsu, Takashi ; Shinoda, Toshio ; Shoji, Tetsuo ; Suzuki, Kazuyuki ; Taniguchi, Masatomo ; Tsuchida, Kenji ; Nakamoto, Hidetomo ; Nishi, Hiroshi ; Hashimoto, Seiji ; Hasegawa, Takeshi ; Hanafusa, Norio ; Hamano, Takayuki ; Fujii, Naohiko ; Masakane, Ikuto ; Marubayashi, Seiji ; Morita, Osamu ; Yamagata, Kunihiro ; Wakai, Kenji ; Wada, Atsushi ; Watanabe, Yuzo ; Tsubakihara, Yoshiharu. / An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010). In: Therapeutic Apheresis and Dialysis. 2012 ; Vol. 16, No. 6. pp. 483-521.
@article{58dd3528e6ea4bc5acef8a0ff11c00db,
title = "An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)",
abstract = "A nationwide statistical survey of 4226 dialysis facilities was conducted at the end of 2010, and 4166 facilities (98.6{\%}) responded. The number of new patients introduced into dialysis was 37512 in 2010. This number has decreased for two consecutive years since it peaked in 2008. The number of patients who died in 2010 was 28882, which has been increasing every year. The number of patients undergoing dialysis at the end of 2010 was 298252, which is an increase of 7591 (2.6{\%}) compared with that at the end of 2009. The number of dialysis patients per million at the end of 2010 was 2329.1. The crude death rate of dialysis patients in 2010 was 9.8{\%}, and has been gradually increasing. The mean age of the new patients introduced into dialysis was 67.8 years and the mean age of the entire dialysis patient population was 66.2 years. Regarding the primary disease of the new patients introduced into dialysis, the percentage of patients with diabetic nephropathy was 43.6{\%}, which is a slight decrease from that in the previous year (44.5{\%}). Patients with diabetic nephropathy as the primary disease accounted for 35.9{\%} of the entire dialysis patient population, which approaches the percentage of patients with chronic glomerulonephritis as the primary disease (36.2{\%}). The percentage of patients who had undergone carpal tunnel release surgery (CTx) was 4.3{\%}, which is a slight decrease from that at the end of 1999 (5.5{\%}). The decrease in the percentage of patients who had undergone CTx was significant among the patients with dialysis durations of 20-24 years (1999, 48.0{\%}; 2010, 23.2{\%}). A total weekly Kt/V attributable to peritoneal dialysis and their residual functional kidney was 1.7 or higher for 59.4{\%} of patients who underwent peritoneal dialysis.",
keywords = "Combined use of peritoneal dialysis, Dementia, Dialysis patient population, Survey, Survival rate",
author = "Shigeru Nakai and Kunitoshi Iseki and Noritomo Itami and Satoshi Ogata and Kazama, {Junichiro James} and Naoki Kimata and Takashi Shigematsu and Toshio Shinoda and Tetsuo Shoji and Kazuyuki Suzuki and Masatomo Taniguchi and Kenji Tsuchida and Hidetomo Nakamoto and Hiroshi Nishi and Seiji Hashimoto and Takeshi Hasegawa and Norio Hanafusa and Takayuki Hamano and Naohiko Fujii and Ikuto Masakane and Seiji Marubayashi and Osamu Morita and Kunihiro Yamagata and Kenji Wakai and Atsushi Wada and Yuzo Watanabe and Yoshiharu Tsubakihara",
year = "2012",
month = "12",
doi = "10.1111/j.1744-9987.2012.01143.x",
language = "English (US)",
volume = "16",
pages = "483--521",
journal = "Therapeutic Apheresis and Dialysis",
issn = "1744-9979",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)

AU - Nakai, Shigeru

AU - Iseki, Kunitoshi

AU - Itami, Noritomo

AU - Ogata, Satoshi

AU - Kazama, Junichiro James

AU - Kimata, Naoki

AU - Shigematsu, Takashi

AU - Shinoda, Toshio

AU - Shoji, Tetsuo

AU - Suzuki, Kazuyuki

AU - Taniguchi, Masatomo

AU - Tsuchida, Kenji

AU - Nakamoto, Hidetomo

AU - Nishi, Hiroshi

AU - Hashimoto, Seiji

AU - Hasegawa, Takeshi

AU - Hanafusa, Norio

AU - Hamano, Takayuki

AU - Fujii, Naohiko

AU - Masakane, Ikuto

AU - Marubayashi, Seiji

AU - Morita, Osamu

AU - Yamagata, Kunihiro

AU - Wakai, Kenji

AU - Wada, Atsushi

AU - Watanabe, Yuzo

AU - Tsubakihara, Yoshiharu

PY - 2012/12

Y1 - 2012/12

N2 - A nationwide statistical survey of 4226 dialysis facilities was conducted at the end of 2010, and 4166 facilities (98.6%) responded. The number of new patients introduced into dialysis was 37512 in 2010. This number has decreased for two consecutive years since it peaked in 2008. The number of patients who died in 2010 was 28882, which has been increasing every year. The number of patients undergoing dialysis at the end of 2010 was 298252, which is an increase of 7591 (2.6%) compared with that at the end of 2009. The number of dialysis patients per million at the end of 2010 was 2329.1. The crude death rate of dialysis patients in 2010 was 9.8%, and has been gradually increasing. The mean age of the new patients introduced into dialysis was 67.8 years and the mean age of the entire dialysis patient population was 66.2 years. Regarding the primary disease of the new patients introduced into dialysis, the percentage of patients with diabetic nephropathy was 43.6%, which is a slight decrease from that in the previous year (44.5%). Patients with diabetic nephropathy as the primary disease accounted for 35.9% of the entire dialysis patient population, which approaches the percentage of patients with chronic glomerulonephritis as the primary disease (36.2%). The percentage of patients who had undergone carpal tunnel release surgery (CTx) was 4.3%, which is a slight decrease from that at the end of 1999 (5.5%). The decrease in the percentage of patients who had undergone CTx was significant among the patients with dialysis durations of 20-24 years (1999, 48.0%; 2010, 23.2%). A total weekly Kt/V attributable to peritoneal dialysis and their residual functional kidney was 1.7 or higher for 59.4% of patients who underwent peritoneal dialysis.

AB - A nationwide statistical survey of 4226 dialysis facilities was conducted at the end of 2010, and 4166 facilities (98.6%) responded. The number of new patients introduced into dialysis was 37512 in 2010. This number has decreased for two consecutive years since it peaked in 2008. The number of patients who died in 2010 was 28882, which has been increasing every year. The number of patients undergoing dialysis at the end of 2010 was 298252, which is an increase of 7591 (2.6%) compared with that at the end of 2009. The number of dialysis patients per million at the end of 2010 was 2329.1. The crude death rate of dialysis patients in 2010 was 9.8%, and has been gradually increasing. The mean age of the new patients introduced into dialysis was 67.8 years and the mean age of the entire dialysis patient population was 66.2 years. Regarding the primary disease of the new patients introduced into dialysis, the percentage of patients with diabetic nephropathy was 43.6%, which is a slight decrease from that in the previous year (44.5%). Patients with diabetic nephropathy as the primary disease accounted for 35.9% of the entire dialysis patient population, which approaches the percentage of patients with chronic glomerulonephritis as the primary disease (36.2%). The percentage of patients who had undergone carpal tunnel release surgery (CTx) was 4.3%, which is a slight decrease from that at the end of 1999 (5.5%). The decrease in the percentage of patients who had undergone CTx was significant among the patients with dialysis durations of 20-24 years (1999, 48.0%; 2010, 23.2%). A total weekly Kt/V attributable to peritoneal dialysis and their residual functional kidney was 1.7 or higher for 59.4% of patients who underwent peritoneal dialysis.

KW - Combined use of peritoneal dialysis

KW - Dementia

KW - Dialysis patient population

KW - Survey

KW - Survival rate

UR - http://www.scopus.com/inward/record.url?scp=84870559642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870559642&partnerID=8YFLogxK

U2 - 10.1111/j.1744-9987.2012.01143.x

DO - 10.1111/j.1744-9987.2012.01143.x

M3 - Article

C2 - 23190510

AN - SCOPUS:84870559642

VL - 16

SP - 483

EP - 521

JO - Therapeutic Apheresis and Dialysis

JF - Therapeutic Apheresis and Dialysis

SN - 1744-9979

IS - 6

ER -